Literature DB >> 11351145

Aggravating effect of cigarette smoke exposure on experimental colitis is associated with leukotriene B(4) and reactive oxygen metabolites.

X Guo1, J K Ko, Q B Mei, C H Cho.   

Abstract

BACKGROUND/AIMS: Cigarette smoking is closely related to the development and recurrence of inflammatory bowel disease (IBD). The present study aimed to investigate the underlying mechanisms of the adverse action of cigarette smoke (CS) exposure on trinitrobenzene sulfonic acid (TNBS)-induced IBD.
METHODS: Rats were preexposed to CS once daily for 4 days before receiving a TNBS enema, and they were killed 24 h afterwards. The colonic myeloperoxidase (MPO) and xanthine oxidase (XO) activities, leukotriene B(4) (LTB(4)) and glutathione (GSH) levels, as well as the production of reactive oxygen metabolites (ROMs) were measured.
RESULTS: CS preexposure significantly augmented the adverse effects of the TNBS enema on colonic damage and increase in MPO activity, while it did not significantly alter the XO activity. Meanwhile, the elevation of ROM production and LTB(4) concentration in colonic tissues after the TNBS enema was also markedly enhanced by CS exposure. In contrast, the depressive action of the TNBS enema on cellular antioxidant GSH levels was reduced further by CS exposure. Pretreatment with a specific LTB(4) antagonist, ONO-4057, protected against colonic damage, particularly in the CS group.
CONCLUSION: CS exposure aggravated experimental IBD. This adverse action could be due to the depletion of GSH together with overproduction of LTB(4), followed by the accumulation of neutrophils and ROMs in the colonic tissue. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351145     DOI: 10.1159/000051887

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Sumiyo Yamashita; Satoru Tanaka; Genjiro Kimura
Journal:  Vasc Health Risk Manag       Date:  2011-07-19

Review 2.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

3.  Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats.

Authors:  QiQi Zhou; Robert M Caudle; Donald D Price; Arseima Y Del Valle-Pinero; G Nicholas Verne
Journal:  Mol Pain       Date:  2006-01-17       Impact factor: 3.395

Review 4.  Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Authors:  Tian Tian; Ziling Wang; Jinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

Review 5.  Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease.

Authors:  Siyan Stewart Cao
Journal:  Gastroenterol Res Pract       Date:  2018-06-20       Impact factor: 2.260

6.  The reduction of DSS-induced colitis severity in mice exposed to cigarette smoke is linked to immune modulation and microbial shifts.

Authors:  Giuseppe Lo Sasso; Blaine W Phillips; Alain Sewer; James N D Battey; Athanasios Kondylis; Marja Talikka; Bjoern Titz; Emmanuel Guedj; Dariusz Peric; David Bornand; Remi Dulize; Celine Merg; Maica Corciulo; Sonia Ouadi; Rendy Yanuar; Ching Keong Tung; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

7.  Chronic Exposure to Cigarette Smoke Affects the Ileum and Colon of Guinea Pigs Differently. Relaxin (RLX-2, Serelaxin) Prevents Most Local Damage.

Authors:  Chiara Traini; Silvia Nistri; Laura Calosi; Maria Giuliana Vannucchi
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

8.  Nicotine Inhibits Clostridium difficile Toxin A-Induced Colitis but Not Ileitis in Rats.

Authors:  Steven R Vigna
Journal:  Int J Inflam       Date:  2016-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.